lunes, 9 de febrero de 2026
Bridging the gap between models and the living body ++++ Efferent Labs’ implantable biosensor provides real-time, continuous insight into how drugs interact with living systems.
Bridging the gap between models and the living body
Efferent Labs’ implantable biosensor provides real-time, continuous insight into how drugs interact with living systems.
https://www.drugdiscoverynews.com/bridging-the-gap-between-models-and-the-living-body-16939
Study identifies molecular drivers of drug resistance in HER2-positive breast cancer
Multi-omics analysis reveals a nine-gene signature linked to treatment failure in aggressive tumor behavior.
https://www.drugdiscoverynews.com/study-identifies-molecular-drivers-of-drug-resistance-in-her2-positive-breast-cancer-16980?utm_campaign=DDN_Newsletter_Science%20Spotlight&utm_medium=email&_hsenc=p2ANqtz-9RBkI91pt9hpMzzVdvUdEYqnBcHnCZHyGR0nMP-yx8yCLVjjpRCLStE8Z4DMPic2K7vYdyiko9HV8BYcEC1eLtf1BApA&_hsmi=402545140&utm_content=402545140&utm_source=hs_email
Endometriosis research shifts toward earlier diagnosis and personalized treatment
After decades of slow progress, advances in molecular profiling and organoid technology are creating new pathways for non-invasive diagnosis and targeted treatment of endometriosis.
https://www.drugdiscoverynews.com/endometriosis-research-shifts-toward-earlier-diagnosis-and-personalized-treatment-16975?utm_campaign=DDN_Newsletter_Science%20Spotlight&utm_medium=email&_hsenc=p2ANqtz-8A1HvURGNK6hcYxI-CKSP7TqnCI0CYLAGZ73IHowDLfJeIbHHs9dBTBMlNYaGgekxRZzZ_7p03v02AnyJ-8GJX2OBqxQ&_hsmi=402545140&utm_content=402545140&utm_source=hs_email
Weekly Rundown: EMA and FDA set shared standards for AI use across drug development
Vaccination guidances, promising trial outcomes, funding bills and more led the news this week.
https://www.drugdiscoverynews.com/weekly-rundown-ema-and-fda-set-shared-standards-for-ai-use-across-drug-development-16994?utm_campaign=DDN_Newsletter_Science%20Spotlight&utm_medium=email&_hsenc=p2ANqtz-9zNGYkHhlDcrDoe3vpS3Rpkc-mJX4N6BezzQFONAW1Rqe-yCEsAHMldSDEiso_m7vJGh8E9wZSFIZTUcWc1e_ihhXtXw&_hsmi=402545140&utm_content=402545140&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario